Pharvaris Bv Stock Analysis

PHVS Stock  USD 23.37  0.13  0.55%   
Pharvaris BV is fairly valued with Real Value of 22.59 and Target Price of 24.15. The main objective of Pharvaris stock analysis is to determine its intrinsic value, which is an estimate of what Pharvaris BV is worth, separate from its market price. There are two main types of Pharvaris' stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Pharvaris' performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Pharvaris' stock to identify patterns and trends that may indicate its future price movements.
The Pharvaris stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Pharvaris is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. Pharvaris Stock trading window is adjusted to America/New York timezone. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Pharvaris' ongoing operational relationships across important fundamental and technical indicators.
  
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pharvaris BV. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real.

Pharvaris Stock Analysis Notes

About 86.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 3.29. Pharvaris BV had not issued any dividends in recent years. Pharvaris N.V., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases. The company was incorporated in 2015 and is based in Leiden, the Netherlands. Pharvaris is traded on NASDAQ Exchange in the United States. To find out more about Pharvaris BV contact CPA MBA at 31 71 203 6410 or learn more at https://pharvaris.com.

Pharvaris BV Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Pharvaris' investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Pharvaris BV or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Pharvaris BV generated a negative expected return over the last 90 days
Pharvaris BV has high historical volatility and very poor performance
Pharvaris BV has high likelihood to experience some financial distress in the next 2 years
Net Loss for the year was (107.32 M) with profit before overhead, payroll, taxes, and interest of 0.
Pharvaris BV currently holds about 201.38 M in cash with (89.65 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.96.
Pharvaris BV has a frail financial position based on the latest SEC disclosures
Over 86.0% of the company shares are owned by institutional investors
Latest headline from news.google.com: Pharvaris Outperform Rating Reaffirmed at Wedbush - Defense World

Pharvaris BV Upcoming and Recent Events

Earnings reports are used by Pharvaris to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Pharvaris previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
3rd of April 2024
Upcoming Quarterly Report
View
13th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
3rd of April 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Pharvaris Largest EPS Surprises

Earnings surprises can significantly impact Pharvaris' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2022-09-12
2022-06-30-0.57-0.380.1933 
2021-05-26
2021-03-31-0.34-0.66-0.3294 
2022-12-08
2022-09-30-0.63-0.250.3860 
View All Earnings Estimates

Pharvaris Market Capitalization

The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.26 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Pharvaris's market, we take the total number of its shares issued and multiply it by Pharvaris's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Pharvaris Profitablity

Pharvaris' profitability indicators refer to fundamental financial ratios that showcase Pharvaris' ability to generate income relative to its revenue or operating costs. If, let's say, Pharvaris is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Pharvaris' executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Pharvaris' profitability requires more research than a typical breakdown of Pharvaris' financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
Last ReportedProjected for 2024
Return On Capital Employed(0.52)(0.55)
Return On Assets(0.41)(0.43)
Return On Equity(0.46)(0.48)

Management Efficiency

Pharvaris BV has return on total asset (ROA) of (0.3132) % which means that it has lost $0.3132 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.6345) %, meaning that it created substantial loss on money invested by shareholders. Pharvaris' management efficiency ratios could be used to measure how well Pharvaris manages its routine affairs as well as how well it operates its assets and liabilities. Return On Capital Employed is likely to drop to -0.55 in 2024. Return On Assets is likely to drop to -0.43 in 2024. At this time, Pharvaris' Total Assets are comparatively stable compared to the past year. Non Current Assets Total is likely to gain to about 1.1 M in 2024, whereas Other Current Assets are likely to drop slightly above 411.6 K in 2024.
Last ReportedProjected for 2024
Price Book Value Ratio 2.73  2.59 
Enterprise Value Multiple(2.00)(2.10)
Price Fair Value 2.73  2.59 
The analysis of Pharvaris' management efficiency is an essential part of evaluating and assessing the financial and operational performance of the entity. It is also vital to analyze Pharvaris' future growth prospects and the overall market conditions to determine the value and potential of its stock. The analysis involves studying a range of financial metrics such as revenue, earnings, profit margins, cash flow, debt, market share, and external factors such as economic trends, industry outlook, competition, and government regulations. The goal of Pharvaris Stock analysis is to determine whether it is undervalued, fairly valued, or overvalued and to make informed investment decisions.
Beta
(3.11)

Technical Drivers

As of the 28th of March, Pharvaris holds the Risk Adjusted Performance of (0.01), coefficient of variation of (3,316), and Variance of 17.11. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Pharvaris, as well as the relationship between them. Put it differently, you can use this information to find out if the company will indeed mirror its model of past market data, or the prices will eventually revert. We were able to interpolate and analyze data for thirteen technical drivers for Pharvaris BV, which can be compared to its competitors. Please check Pharvaris BV market risk adjusted performance and treynor ratio to decide if Pharvaris BV is priced some-what accurately, providing market reflects its current price of 23.37 per share. Given that Pharvaris has information ratio of (0.06), we recommend you to check out Pharvaris BV's recent market performance to make sure the company can sustain itself at a future point.

Pharvaris BV Price Movement Analysis

Execute Study
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Pharvaris middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Pharvaris BV. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

Pharvaris Predictive Daily Indicators

Pharvaris intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Pharvaris stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Pharvaris Corporate Filings

6K
6th of March 2024
A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges.
ViewVerify
6K
16th of February 2024
A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges.
ViewVerify
13A
14th of February 2024
An amended filing to the original Schedule 13G
ViewVerify
13A
13th of February 2024
An amended filing to the original Schedule 13G
ViewVerify
13A
9th of February 2024
An amended filing to the original Schedule 13G
ViewVerify
13A
8th of February 2024
An amended filing to the original Schedule 13G
ViewVerify
6K
7th of February 2024
A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges.
ViewVerify
F3
25th of January 2024
An amendment to the original Schedule 13D filing
ViewVerify

Pharvaris Forecast Models

Pharvaris' time-series forecasting models are one of many Pharvaris' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Pharvaris' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Pharvaris Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Pharvaris prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Pharvaris shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Pharvaris. By using and applying Pharvaris Stock analysis, traders can create a robust methodology for identifying Pharvaris entry and exit points for their positions.
Last ReportedProjected for 2024
Pretax Profit Margin 0.00  0.00 
Operating Profit Margin 0.00  0.00 
Net Profit Margin 0.00  0.00 
Gross Profit Margin 0.00  0.00 

Current Pharvaris Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Pharvaris analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Pharvaris analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
24.15Strong Buy6Odds
Pharvaris BV current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Pharvaris analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Pharvaris stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Pharvaris BV, talking to its executives and customers, or listening to Pharvaris conference calls.
Pharvaris Analyst Advice Details

Pharvaris Stock Analysis Indicators

Pharvaris BV stock analysis indicators help investors evaluate how Pharvaris stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Pharvaris shares will generate the highest return on investment. By understating and applying Pharvaris stock analysis, traders can identify Pharvaris position entry and exit signals to maximize returns.
Begin Period Cash Flow197.7 M
Common Stock Shares Outstanding33.6 M
Total Stockholder Equity149.3 M
Tax Provision604.3 K
Property Plant And Equipment Net626.4 K
Cash And Short Term Investments161.8 M
Cash161.8 M
Accounts PayableM
Net Debt-161.4 M
50 Day M A26.7998
Total Current Liabilities18.2 M
Non Current Assets Total886.2 K
Stock Based Compensation11.4 M
When determining whether Pharvaris BV is a strong investment it is important to analyze Pharvaris' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Pharvaris' future performance. For an informed investment choice regarding Pharvaris Stock, refer to the following important reports:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pharvaris BV. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real.
You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.

Complementary Tools for Pharvaris Stock analysis

When running Pharvaris' price analysis, check to measure Pharvaris' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharvaris is operating at the current time. Most of Pharvaris' value examination focuses on studying past and present price action to predict the probability of Pharvaris' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharvaris' price. Additionally, you may evaluate how the addition of Pharvaris to your portfolios can decrease your overall portfolio volatility.
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Equity Valuation
Check real value of public entities based on technical and fundamental data
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Is Pharvaris' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pharvaris. If investors know Pharvaris will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pharvaris listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(3.29)
Return On Assets
(0.31)
Return On Equity
(0.63)
The market value of Pharvaris BV is measured differently than its book value, which is the value of Pharvaris that is recorded on the company's balance sheet. Investors also form their own opinion of Pharvaris' value that differs from its market value or its book value, called intrinsic value, which is Pharvaris' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pharvaris' market value can be influenced by many factors that don't directly affect Pharvaris' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pharvaris' value and its price as these two are different measures arrived at by different means. Investors typically determine if Pharvaris is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pharvaris' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.